Type I von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers:: a possible general mechanism for dominant mutations of oligomeric proteins

被引:68
作者
Bodó, I
Katsumi, A
Tuley, EA
Eikenboom, JCJ
Dong, ZY
Sadler, JE
机构
[1] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Biochem Med, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Mol Biophys, St Louis, MO 63110 USA
[4] Leiden Univ, Ctr Med, Dept Hematol, NL-2300 RA Leiden, Netherlands
[5] Leiden Univ, Ctr Med, Hemostasis & Thrombosis Res Ctr, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1182/blood.V98.10.2973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Some families affected by von Willebrand disease type 1 show high penetrance with exceptionally low von Willebrand factor (VWF) levels. Previously, a mutation associated with this dominant phenotype, Cys1149Arg, was found to decrease the secretion of coexpressed normal VWF, and the mutation was proposed to cause intracellular retention of pro-VWF heterodimers. To demonstrate heterodimer formation, a model was developed in which subunits could be distinguished immunologically and by size. Recombinant VWF lacking domain Al (dA1), A3 (dA3), or both (dA13) was secreted efficiently as a full range of multimers. Cotransfection of Cys1149Arg and dA13 resuited in the secretion of multimeric VWF containing about 250 kd (Cys1149Arg) and about 210 kd (dA13). Cell lysates contained pro-VWF forms of Cys1149Arg and dA13. Immunoprecipitation with an antidomain Al antibody recovered both subunits in heterodimers, and subunit ratios were consistent with random dimerization. Similar results were obtained for cotransfection of Cys1149Arg and dA1. Normal VWF has a Cys1149-Cys1169 intrachain bond. When cotransfected with normal VWF, Cys1149Arg or the double mutant Cys1149Arg+Cys1169Ser caused a similar decrease in VWF secretion, suggesting that an unpaired Cys1169 does not explain the intracellular retention of Cys1149Arg. VWF Cys1149Arg was not secreted from BHK cells but was degraded intracellularly within about 4 hours, and the proteasome inhibitor lactacystin delayed Its clearance more than 16 hours. Thus, dominant von Willebrand disease type I may be caused by heterodimerization of mutant and normal subunits in the endoplasmic reticulum followed by proteasomal degradation in the cytoplasm. A similar dominant negative mechanism could cause quantitative deficiencies of other multisubunit proteins. (C) 2001 by The American Society of Hematology.
引用
收藏
页码:2973 / 2979
页数:7
相关论文
共 42 条
[11]   Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor [J].
Eikenboom, JCJ ;
Matsushita, T ;
Reitsma, PH ;
Tuley, EA ;
Castaman, G ;
Briet, E ;
Sadler, JE .
BLOOD, 1996, 88 (07) :2433-2441
[12]   Setting the standards: Quality control in the secretory pathway [J].
Ellgaard, L ;
Molinari, M ;
Helenius, A .
SCIENCE, 1999, 286 (5446) :1882-1888
[13]   Lactacystin, proteasome function, and cell fate [J].
Fenteany, G ;
Schreiber, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8545-8548
[14]   SUBSTRUCTURE OF HUMAN VONWILLEBRAND-FACTOR [J].
FOWLER, WE ;
FRETTO, LJ ;
HAMILTON, KK ;
ERICKSON, HP ;
MCKEE, PA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) :1491-1500
[15]   QUALITY-CONTROL OF ER SYNTHESIZED PROTEINS - AN EXPOSED THIOL-GROUP AS A 3-WAY SWITCH MEDIATING ASSEMBLY, RETENTION AND DEGRADATION [J].
FRA, AM ;
FAGIOLI, C ;
FINAZZI, D ;
SITIA, R ;
ALBERINI, CM .
EMBO JOURNAL, 1993, 12 (12) :4755-4761
[16]  
FRETTO LJ, 1986, J BIOL CHEM, V261, P5679
[17]  
GILL JC, 1987, BLOOD, V69, P1691
[18]  
GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177
[19]   QUALITY-CONTROL IN THE SECRETORY PATHWAY - RETENTION OF A MISFOLDED VIRAL MEMBRANE GLYCOPROTEIN INVOLVES CYCLING BETWEEN THE ER, INTERMEDIATE COMPARTMENT, AND GOLGI-APPARATUS [J].
HAMMOND, C ;
HELENIUS, A .
JOURNAL OF CELL BIOLOGY, 1994, 126 (01) :41-52
[20]  
HOLMBERG L, 1992, EUR J HAEMATOL, V48, P127